Cutia Therapeutics

HK$0.67As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2487Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR (65.75%)
Div yield —
ROE (38.30%)
Biotechnology
Beta (5Y) 0.86
PE TTM —
TSR TTM (91.10%)
Mkt cap HK$250.0M
ROIC (15.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.722
7.77%
(32.43%)
Hold 11|1|11|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
21.43%
12.11%
28.80%
23.95%
Revenue¥M
20.87
21.68
21.52
21.63
4.23%
6.91%
7.17%
6.56%
Peers (US$31.89M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.086
0.320
0.335
EBIT/Intx
0.367
0.467
0.465
Own earn%
0.76
(115.77)
(111.97)
Sh yield%
43.55
31.27
29.76
Owners
Insiders/Inst%
9.69
31.84
Short interest%
5.52
SBC / revenue%
0.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
12–18
$1 testx
0.1
Incr. ROIC%
7